RESUMO
RESUMO Objetivo: Identificar o perfil dos doadores de tecidos oculares humanos na área de atuação do Banco de Olhos da Paraíba, destacando o impacto da sorologia positiva para hepatite B no descarte dos tecidos para transplante. Métodos: O estudo é transversal e utilizou dados do Banco de Olhos da Paraíba entre janeiro de 2013 e dezembro de 2022. Dados sobre procedência, idade, sexo, causa do óbito, tempo entre óbito e enucleação, resultados sorológicos e motivo de descarte das córneas dos doadores foram coletados. Resultados: O maior motivo de descarte foi por sorologia positiva (56,5%), sendo positivadas as sorologias positivas para hepatite B e HBsAg em 11,1% e 4,75% dos pacientes, respectivamente. Conclusão: A sorologia positiva para hepatite B como um critério de descarte absoluto é responsável por grande parcela de descartes, apesar da pouca informação sobre suas repercussões e representação de infectividade nos receptores do transplante.
ABSTRACT Objective: To identify the profile of human ocular tissue donors in the area covered by the Eye Bank of Paraíba (PB), highlighting the impact of positive serology for hepatitis B (anti-HBc) in the disposal of tissues for transplantation. Methods: This is a cross-sectional that uses data from the Eye Bank of Paraíba (PB) between January 2013 and December 2022. Data on origin, age, sex, cause of death, time between death and enucleation, serological results, and reason for discarded donor corneas were collected. Results: The main reason for discarding was due to positive serology (56.5%), with positive anti-HBc and HBsAg serology in 11.1% and 4.75% of patients, respectively. Conclusion: Anti-HBc positive serology as an absolute disposal criterion is responsible for great part of disposals, despite little information about its repercussions and representation of infectivity in transplant recipients.
Assuntos
Humanos , Masculino , Feminino , Pré-Escolar , Criança , Adolescente , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Doadores de Tecidos/estatística & dados numéricos , Transplante de Córnea/normas , Transplante de Córnea/estatística & dados numéricos , Seleção do Doador/normas , Bancos de Olhos/normas , Anticorpos Anti-Hepatite B/análise , Testes Sorológicos/normas , Vírus da Hepatite B , Estudos Transversais , Estudos Retrospectivos , Transmissão de Doença Infecciosa/legislação & jurisprudência , Transmissão de Doença Infecciosa/prevenção & controle , Transmissão de Doença Infecciosa/estatística & dados numéricos , Bancos de Olhos/estatística & dados numéricos , Hepatite B/prevenção & controle , Hepatite B/transmissão , Antígenos do Núcleo do Vírus da Hepatite B/análiseRESUMO
Multi-state models can capture the different patterns of disease evolution. In particular, the illness-death model is used to follow disease progression from a healthy state to an intermediate state of the disease and to a death-related final state. We aim to use those models in order to adapt treatment decisions according to the evolution of the disease. In state-of-the art methods, the risks of transition between the states are modeled via (semi-) Markov processes and transition-specific Cox proportional hazard (P.H.) models. The Cox P.H. model assumes that each variable makes a linear contribution to the model, but the relationship between covariates and risks can be more complex in clinical situations. To address this challenge, we propose a neural network architecture called illness-death network (IDNetwork) that relaxes the linear Cox P.H. assumption within an illness-death process. IDNetwork employs a multi-task architecture and uses a set of fully connected subnetworks in order to learn the probabilities of transition. Through simulations, we explore different configurations of the architecture and demonstrate the added value of our model. IDNetwork significantly improves the predictive performance compared to state-of-the-art methods on a simulated data set, on two clinical trials for patients with colon cancer and on a real-world data set in breast cancer.
Assuntos
Transmissão de Doença Infecciosa , Redes Neurais de Computação , Progressão da Doença , Transmissão de Doença Infecciosa/estatística & dados numéricos , Humanos , Cadeias de Markov , Probabilidade , Prognóstico , Modelos de Riscos Proporcionais , Fatores de Risco , Estados UnidosRESUMO
Objetivo: conhecer as representações sociais de universitários brasileiros sobre o uso de máscaras para o controle da COVID-19. Método: estudo qualitativo, tipo survey, ancorado na Teoria das Representações Sociais. Participaram 283 universitários brasileiros, selecionados por conveniência. Os dados foram coletados por meio de formulário digital. Para análise, utilizou-se a Análise Temática. Resultados: elaborou-se um tema nomeado "A máscara para prevenção: materialização do medo de contágio", e três subtemas, intitulados respectivamente "A construção de um novo hábito: o mal necessário das máscaras"; "O macrossocial na modificação do eu" e "O uso da máscara no dia-a-dia: a individualização do social". Conclusão: observou-se a compreensão do uso de máscaras como um recurso para prevenção de uma condição ameaçadora à vida. Atitudes favoráveis parecem se organizar em contraposição ao medo causado pelo vírus e suas consequências.
Objective: to know the social representations of brazilian university students about the use of masks to control COVID-19. Method: qualitative survey, based on the Theory of Social Representations. 283 brazilian university students were selected by convenience. Data were collected through digital form. For analysis, the Thematic Analysis was used. Results: a theme named "The mask for prevention: materialization of the fear of contagion" was elaborated, and three sub-themes, respectively titled "The construction of a new habit: the necessary evil of masks"; "The macrosocial in the modification of the self" and "The use of the mask in everyday life: the individualization of the social". Conclusion: the understanding of the use of masks as a resource for preventing a life-threatening condition was observed. These favorable attitudes seem to be organized in contrast to the fear caused by virus and their consequences.
Objetivo: conocer las representaciones sociales de estudiantes universitarios brasileños sobre el uso de máscaras para el control de COVID-19. Método: estudio cualitativo, basado en la Teoría de las Representaciones Sociales. Participaron 283 universitarios brasileños, seleccionados por conveniencia. Los datos fueron recolectados a través de un formulario digital. Para el análisis se utilizó el Análisis Temático. Resultados: se elaboró un tema denominado "La mascarilla para la prevención: materialización del miedo al contagio" y tres subtemas, respectivamente titulados "La construcción de un nuevo hábito: el mal necesario de las máscaras"; "Lo macrosocial en la modificación del yo" y "El uso de la mascarilla en la vida cotidiana: la individualización de lo social". Conclusión: se observó la comprensión del uso de máscaras como recurso para la prevención de una condición potencialmente mortal. Estas actitudes favorables parecen organizarse en contraste con el miedo provocado por el virus y sus consecuencias.
Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Pessoa de Meia-Idade , Adulto Jovem , Estudantes/estatística & dados numéricos , Conhecimentos, Atitudes e Prática em Saúde , COVID-19/prevenção & controle , Máscaras/estatística & dados numéricos , Saúde do Estudante , Inquéritos e Questionários/estatística & dados numéricos , Transmissão de Doença Infecciosa/estatística & dados numéricos , Pesquisa Qualitativa , Prevenção de Doenças , COVID-19/psicologiaAssuntos
Vacinas contra COVID-19 , COVID-19/prevenção & controle , Hospedeiro Imunocomprometido , Imunogenicidade da Vacina , Vacinas Sintéticas , Adenoviridae , Anticorpos Antivirais/sangue , COVID-19/transmissão , Vacinas contra COVID-19/administração & dosagem , Vacinas contra COVID-19/imunologia , Transmissão de Doença Infecciosa/prevenção & controle , Transmissão de Doença Infecciosa/estatística & dados numéricos , Vetores Genéticos , Humanos , Fatores de Tempo , Vacinas de Produtos Inativados , Vacinas Sintéticas/administração & dosagem , Vacinas Sintéticas/imunologia , Vacinas de mRNAAssuntos
COVID-19 , Controle de Doenças Transmissíveis , Transmissão de Doença Infecciosa , Pandemias , Tuberculose , COVID-19/epidemiologia , COVID-19/terapia , COVID-19/transmissão , Controle de Doenças Transmissíveis/métodos , Controle de Doenças Transmissíveis/organização & administração , Transmissão de Doença Infecciosa/prevenção & controle , Transmissão de Doença Infecciosa/estatística & dados numéricos , Necessidades e Demandas de Serviços de Saúde/tendências , Humanos , Índia/epidemiologia , Programas Nacionais de Saúde/organização & administração , Programas Nacionais de Saúde/normas , Programas Nacionais de Saúde/estatística & dados numéricos , Pandemias/prevenção & controle , Pandemias/estatística & dados numéricos , SARS-CoV-2 , Tuberculose/epidemiologia , Tuberculose/terapia , Tuberculose/transmissão , Organização Mundial da SaúdeRESUMO
OBJECTIVES/HYPOTHESIS: Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) is transmitted by droplet as well as airborne infection. Surgical patients are vulnerable to the infection during their hospital admission. Some surgical procedures are classified as aerosol generating (AGP). STUDY DESIGN: Retrospective observational study of four specialties associates with known AGP's during the 4 months of the first wave of UK COVID-19 epidermic to identify post-surgical cross-infection with SARSCoV-2 within 14 days of a procedure. METHODS: Retrospective observational study in a tertiary healthcare center of four specialties associates with known AGP's during the 4 months of the first wave of UK COVID-19 epidermic to identify post-surgical cross-infection with SARSCoV-2 within 14 days of a procedure. RESULTS: There were 3,410 procedures reported during this period. The overall cross-infection rate from tested patients was 1.3% (4 patients), that is, 0.11% of all operations over 4 months. Ear, nose, and throat carried slightly higher rate of infection (0.4%) than gastroenterology (0.08%). The mortality rate was 0.3% (one gastroenterology patient from 304 positive cases) compared to 0% if surgery performed after recovery from SARSCoV-2 and 37.5% when surgery was conducted during the incubation period of the disease. Routine preoperative rapid screening tests and self-isolation are crucial to avoid the risk of cross-infection. Patients with underlying malignancy or receiving chemotherapy were more prone to pulmonary complications and mortality. CONCLUSION: The risk of SARS-COV-2 cross-infection after surgical procedure is very low. Preoperative screening and self-isolation together with personal protective measures should be in place to minimize the cross-infection. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:E2749-E2754, 2021.
Assuntos
COVID-19/transmissão , Infecção Hospitalar/epidemiologia , Transmissão de Doença Infecciosa/prevenção & controle , Procedimentos Cirúrgicos Operatórios/efeitos adversos , Aerossóis , Idoso , Idoso de 80 Anos ou mais , COVID-19/diagnóstico , COVID-19/epidemiologia , COVID-19/virologia , Infecção Hospitalar/prevenção & controle , Transmissão de Doença Infecciosa/estatística & dados numéricos , Feminino , Humanos , Incidência , Masculino , Programas de Rastreamento/métodos , Pessoa de Meia-Idade , Mortalidade/tendências , Avaliação de Resultados em Cuidados de Saúde , Material Particulado/efeitos adversos , Isolamento de Pacientes/métodos , Equipamento de Proteção Individual/normas , Período Pré-Operatório , Estudos Retrospectivos , Medição de Risco/métodos , SARS-CoV-2/genética , Procedimentos Cirúrgicos Operatórios/classificação , Procedimentos Cirúrgicos Operatórios/estatística & dados numéricos , Reino Unido/epidemiologiaAssuntos
Broncoscopia/métodos , COVID-19/diagnóstico , Transmissão de Doença Infecciosa/estatística & dados numéricos , Hospitais/estatística & dados numéricos , Exposição Ocupacional/efeitos adversos , Pandemias , Recursos Humanos em Hospital , COVID-19/epidemiologia , COVID-19/transmissão , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , SARS-CoV-2 , Estados Unidos/epidemiologiaRESUMO
BACKGROUND: On March 11, 2020, the World Health Organization (WHO) declared Coronavirus Disease (COVID-19) a pandemic. Hospitals around the world began to implement infection prevention and control (IPC) measures to stop further spread and prevent infections within their facilities. Healthcare organizations were challenged to develop response plans, procure personal protective equipment (PPE) that was in limited supply while continuing to provide quality, safe care. METHODS: As a comprehensive cancer center with immunocompromised patients, our efforts began immediately. Preventative measures were established and, as of September 2020, over 14,000 patients have been tested within the facility. From March 2020 through September 2020, only one case of hospital acquired (HA) COVID-19 was identified among our patients. Two cases of suspected community acquired (SCA) cases were also identified. Following the Centers for Disease Control (CDC) guidance, IPC measures were implemented within the facility as information science about the virus developed. This article addresses the IPC measures taken, such as enhancing isolation precautions, implementing screening protocols, disinfecting and reusing N95 respirators, by the center throughout the pandemic as well as the challenges that arouse with a new and emerging infectious disease. CONCLUSIONS: The infection control measures implemented at our comprehensive cancer center during the COVID-19 pandemic allowed our center to continue to provide world class cancer care with minimal COVID-19 infection transmission among patients and team members.
Assuntos
COVID-19/prevenção & controle , Institutos de Câncer , Transmissão de Doença Infecciosa/prevenção & controle , COVID-19/diagnóstico , COVID-19/epidemiologia , COVID-19/transmissão , Transmissão de Doença Infecciosa/estatística & dados numéricos , Humanos , Incidência , Controle de Infecções/métodos , Controle de Infecções/organização & administração , Controle de Infecções/normas , Oncologia , SARS-CoV-2/isolamento & purificaçãoRESUMO
BACKGROUND: Primary care is the major point of access in most health systems in developed countries and therefore for the detection of coronavirus disease 2019 (COVID-19) cases. The quality of its IT systems, together with access to the results of mass screening with Polymerase chain reaction (PCR) tests, makes it possible to analyse the impact of various concurrent factors on the likelihood of contracting the disease. METHODS AND FINDINGS: Through data mining techniques with the sociodemographic and clinical variables recorded in patient's medical histories, a decision tree-based logistic regression model has been proposed which analyses the significance of demographic and clinical variables in the probability of having a positive PCR in a sample of 7,314 individuals treated in the Primary Care service of the public health system of Catalonia. The statistical approach to decision tree modelling allows 66.2% of diagnoses of infection by COVID-19 to be classified with a sensitivity of 64.3% and a specificity of 62.5%, with prior contact with a positive case being the primary predictor variable. CONCLUSIONS: The use of a classification tree model may be useful in screening for COVID-19 infection. Contact detection is the most reliable variable for detecting Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases. The model would support that, beyond a symptomatic diagnosis, the best way to detect cases would be to engage in contact tracing.
Assuntos
COVID-19/diagnóstico , COVID-19/transmissão , Transmissão de Doença Infecciosa/estatística & dados numéricos , Adulto , Idoso , COVID-19/epidemiologia , Estudos de Coortes , Busca de Comunicante , Mineração de Dados/métodos , Árvores de Decisões , Feminino , Humanos , Masculino , Programas de Rastreamento/métodos , Pessoa de Meia-Idade , Probabilidade , Estudos Retrospectivos , SARS-CoV-2/patogenicidade , Sensibilidade e EspecificidadeRESUMO
BACKGROUND: Reducing COVID-19 transmission relies on controlling droplet and aerosol spread. Fluorescein staining reveals microscopic droplets. AIM: To compare the droplet spread in non-laminar and laminar air flow operating theatres. METHODS: A 'cough-generator' was fixed to a theatre trolley at 45°. Fluorescein-stained 'secretions' were projected on to a series of calibrated targets. These were photographed under UV light and 'source detection' software measured droplet splatter size and distance. FINDINGS: The smallest droplet detected was â¼120 µm and the largest â¼24,000 µm. An average of 25,862 spots was detected in the non-laminar theatre, compared with 11,430 in the laminar theatre (56% reduction). The laminar air flow mainly affected the smaller droplets (<1000 µm). The surface area covered with droplets was: 6% at 50 cm, 1% at 2 m, and 0.5% at 3 m in the non-laminar air flow; and 3%, 0.5%, and 0.2% in the laminar air flow, respectively. CONCLUSION: Accurate mapping of droplet spread in clinical environments is possible using fluorescein staining and image analysis. The laminar air flow affected the smaller droplets but had limited effect on larger droplets in our 'aerosol-generating procedure' cough model. Our results indicate that the laminar air flow theatre requires similar post-surgery cleaning to the non-laminar, and staff should consider full personal protective equipment for medium- and high-risk patients.
Assuntos
Aerossóis , Microbiologia do Ar , COVID-19/prevenção & controle , COVID-19/transmissão , Transmissão de Doença Infecciosa/estatística & dados numéricos , Ambiente Controlado , Salas Cirúrgicas/estatística & dados numéricos , Humanos , SARS-CoV-2RESUMO
Implementation of the HIV Organ Policy Equity (HOPE) Act marks a new era in transplantation, allowing organ transplantation from HIV+ donors to HIV+ recipients (HIV D+/R+ transplantation). In this review, we discuss major milestones in HIV and transplantation which paved the way for this landmark policy change, including excellent outcomes in HIV D-/R+ recipient transplantation and success in the South African experience of HIV D+/R+ deceased donor kidney transplantation. Under the HOPE Act, from March 2016 to December 2018, there were 56 deceased donors, and 102 organs were transplanted (71 kidneys and 31 livers). In 2019, the first HIV D+/R+ living donor kidney transplants occurred. Reaching the full estimated potential of HIV+ donors will require overcoming challenges at the community, organ procurement organization, and transplant center levels. Multiple clinical trials are ongoing, which will provide clinical and scientific data to further extend the frontiers of knowledge in this field.
Assuntos
Transmissão de Doença Infecciosa/estatística & dados numéricos , Infecções por HIV/epidemiologia , HIV , Transplante de Órgãos/métodos , Doadores de Tecidos/provisão & distribuição , Transplantados , Comorbidade , Saúde Global , Infecções por HIV/transmissão , HumanosAssuntos
Vacinas contra COVID-19/imunologia , COVID-19 , Controle de Doenças Transmissíveis/métodos , Programas de Imunização/organização & administração , SARS-CoV-2 , Monofosfato de Adenosina/análogos & derivados , Monofosfato de Adenosina/uso terapêutico , África/epidemiologia , Fatores Etários , Alanina/análogos & derivados , Alanina/uso terapêutico , Anticorpos Neutralizantes , Compostos Azabicíclicos/uso terapêutico , COVID-19/epidemiologia , COVID-19/prevenção & controle , COVID-19/terapia , COVID-19/transmissão , Teste para COVID-19 , Vacinas contra COVID-19/administração & dosagem , Vacinas contra COVID-19/efeitos adversos , Dexametasona/uso terapêutico , Transmissão de Doença Infecciosa/prevenção & controle , Transmissão de Doença Infecciosa/estatística & dados numéricos , Humanos , Mutação , Gravidade do Paciente , Quinazolinas/uso terapêutico , Fatores de Risco , SARS-CoV-2/genética , SARS-CoV-2/imunologia , SARS-CoV-2/patogenicidade , SARS-CoV-2/ultraestrutura , Análise de Sequência de RNA , África do Sul/epidemiologia , Virulência/genéticaRESUMO
OBJECTIVE: The COVID-19 pandemic has forced healthcare providers worldwide to bring in changes in the way cancer patients are cared for. Many cancer departments globally have brought in changes to their daily practice. This article is about our experience of evolving "COVID 19 PROTOCOL" devised in our department and taking a shape to suit a health care system with limited budget. MATERIALS AND METHODS: All the patient census & details of department of surgical oncology, Royapettah cancer hospital, from month of March 2020 to July 2020, who were subjected to COVID protocol were compared to patient census of similar duration in immediate past five months of October 2019 to February 2020. The data from out-patient department, ward in-patient census and healthcare personnel data was analyzed. RESULTS: There was a drop to 63.5% in OP census and 61.6% in IP census. There was a drop to 64.5% in number of major cases operated during initial phases of COVID pandemic. Health care workers were also infected with the COVID but cross infectivity can be checked if proper steps to adhere to an institutional protocol based on general measures of cleanliness are taken. CONCLUSION: Adherence to an institutional protocol based on compliance to general measures of masking, hand washing and social distancing plays a major role in minimizing disease spread. The Royapettah COVID protocol, though in process of evolution, can be recommended for any health care center with limited resources.
Assuntos
COVID-19 , Transmissão de Doença Infecciosa/prevenção & controle , Neoplasias , Pandemias , COVID-19/epidemiologia , COVID-19/prevenção & controle , COVID-19/transmissão , Transmissão de Doença Infecciosa/estatística & dados numéricos , Hospitalização/estatística & dados numéricos , Humanos , Neoplasias/epidemiologia , Neoplasias/cirurgia , Neoplasias/terapia , Ambulatório Hospitalar/estatística & dados numéricos , Pandemias/prevenção & controle , Equipamento de Proteção Individual/estatística & dados numéricos , SARS-CoV-2 , Centros de Atenção Terciária/estatística & dados numéricosRESUMO
OBJECTIVE: To quantify the time-varying reproductive rates for SARS-CoV-2 and its implication in Louisiana. SUMMARY OF BACKGROUND DATA: Basic reproductive number (R0) and effective reproductive number (Re or Rt) are 2 measures of the ability of an infectious agent to spread in the environment. They differ in that R0 assumes zero immunity in the population, while Re or Rt accounts for change over time. Reproductive number modeling is influenced by several factors, including serial interval, the time between the onset of symptoms in an infector, and a secondary case. Quantification of the ability of a pathogen to spread is essential in guiding policy. METHODS: Here, we construct epidemic curves and calculate daily Rt values for the state of Louisiana and each of its 9 regions. RESULTS: Our results demonstrated variation over both time and geography in calculated R0 and Rt values. Generally, as time has progressed, predicted R0 and Rt values have decreased. In Louisiana, mean Rt was calculated at 3.07 in March and 0.82 by May. A reproductive number less than one is important as it indicates infectious spread will decline with time. The most recent finding of mean Rt = 0.82 is important. It stands in stark contrast to the situation in April when New Orleans, Louisiana, had the highest per capita coronavirus mortality rate in the United States - twice that of New York City and 4 times the rate in Seattle. CONCLUSION: As locations around the world begin to lift restrictions, monitoring of infectious spread will be essential.
Assuntos
COVID-19/epidemiologia , Controle de Doenças Transmissíveis/métodos , Transmissão de Doença Infecciosa/estatística & dados numéricos , Pandemias , SARS-CoV-2 , COVID-19/transmissão , Seguimentos , Humanos , Fatores de Tempo , Estados Unidos/epidemiologiaRESUMO
Objetivos: Describir variables epidemiológicas clave durante el año 2020 (pandemia de COVID-19) con respecto a la prevención de la transmisión perinatal (TP) del VIH en Ciudad de Buenos Aires (CABA), comparando con períodos previos.Métodos: Análisis retrospectivo de los datos agregados de TP de las principales maternidades de CABA. El año pandémico (2020) se comparó con los años no pandémicos 2018 y 2019.Resultados: Se observó una reducción del total de nacimientos en 2020 en comparación con 2019 y 2018 (11.640 vs. 14.031 y 15,978, respectivamente). La proporción de nacidos vivos en madres VIH+ (MEV) fue 0,88% en 2020, sin diferencia con 2019 y 2018 (0,94% y 0,93%), p> 0,05 para todas las comparaciones. Entre las MEV, el diagnóstico intraparto fue del 2,9% para 2020, sin diferencias con 2019 (2,25%) y 2018 (9,3%), p> 0,05 (todas las comparaciones); el 8,8% comenzó el tratamiento antirretroviral con > 28 semanas de edad gestacional en 2020 frente al 16% y el 18,05% en 2018 y 2019 (p> 0,05, todas las comparaciones). La prevalencia de la carga viral indetectable en el momento del parto fue del 67% en 2020 frente al 64% en 2018 y del 65,4% en 2019 (p> 0,05, todas las comparaciones). La transmisión perinatal fue 0% en 2020 vs. 1,33% en 2018 y 2,25% 2019 (p> 0,05, todas las comparaciones).Conclusiones: En la primera ola de la pandemia de COVID-19 no se observaron cambios en la proporción de MEV asistidas, diagnóstico intraparto de VIH, inicio tardío del TARV y TP en CABA
Background: To describe key epidemiological variables in 2020 (COVID-19 pandemic) regarding prevention of mother-to-child transmission (MTCT) in Buenos Aires city (CABA) in comparison with previous periods. Methods: Retrospective analysis of aggregated MTCT data was gathered from six principal maternity hospitals in Buenos Aires city. Pandemic year (2020) was compared to non-pandemic years 2018-19 individually considering key epidemiological variables. Results: A reduction of total births was observed in 2020 compared to 2019 and 2018 (11640 vs. 14031 and 15978, respectively). Proportion of live births in HIV-infected women (HPW) was 0.88% in 2020 without difference with 2019 and 2018 (0.94% and 0.93%), p> 0.05 for all comparisons. Among HPW, intrapartum diagnosis was 2.9% for 2020, with no difference between 2019 (2.25%) and 2018 (9.3%), p>0.05 (all comparisons); 8.8% had antiretroviral therapy (ART) started > 28 weeks of gestational age in 2020 vs. 16% and 18.05% in 2018 and 2019 (p> 0.05, all comparisons). Prevalence of undetectable viral load at delivery was 67% in 2020 vs 64% in 2018 and 65.4% in 2019 (p> 0.05, all comparisons). Perinatal transmission was 0% in 2020 vs 1.33% in 2018 and 2.25% 2019 (p> 0.05, all comparisons) Conclusions: In first wave of COVID 19 pandemic no changes in the proportion of HPW assisted, HIV intrapartum diagnosis, late ART initiation and MTCT-rate was observed in CABA
Assuntos
Humanos , Feminino , Planos e Programas de Saúde , Declaração de Nascimento , Fatores Epidemiológicos , Incidência , Estudos Retrospectivos , HIV , Transmissão de Doença Infecciosa/estatística & dados numéricosRESUMO
Complications associated with tattoos are mostly of cutaneous origin. They include chiefly ink allergy, local infection, benign tumors or malignant lesions and elective localization of various dermatoses. Tattoo-related systemic diseases and infections have more rarely been described, the most common being sarcoidosis and hepatitis C. However, unusual associations have also been reported, even though they may be anecdotal or likely unrelated with the procedure.
Assuntos
Doença/etiologia , Infecções/etiologia , Tatuagem/efeitos adversos , Transmissão de Doença Infecciosa/estatística & dados numéricos , Humanos , Infecções/epidemiologia , Sarcoidose/epidemiologia , Sarcoidose/etiologia , Pele/patologia , Dermatopatias/epidemiologia , Dermatopatias/etiologia , Tatuagem/estatística & dados numéricosRESUMO
IMPORTANCE: Determine phacoemulsification cataract surgery risk in a Covid-19 era. BACKGROUND: SARS-CoV-2 (Covid-19) transmission via microdroplet and aerosol-generating procedures presents risk to medical professionals. As the most common elective surgical procedure performed globally; determining contamination risk from phacoemulsification cataract surgery may guide personal protection equipment use. DESIGN: Pilot study involving phacoemulsification cataract surgery on enucleated porcine eyes by experienced ophthalmologists in an ophthalmic operating theatre. PARTICIPANTS: Two ophthalmic surgical teams. METHODS: Standardized phacoemulsification of porcine eyes by two ophthalmologists accompanied by an assistant. Fluorescein incorporated into phacoemulsification irrigation fluid identifying microdroplets and spatter. Contamination documented using a single-lens reflex camera with a 532 nm narrow bandpass (fluorescein) filter, in-conjunction with a wide-field blue light and flat horizontal laser beam (wavelength 532 nm). Quantitative image analysis using Image-J software. MAIN OUTCOME MEASURES: Microdroplet and spatter contamination from cataract phacoemulsification. RESULTS: With phacoemulsification instruments fully within the eye, spatter contamination was limited to <10 cm. Insertion and removal of the phacoemulsification needle and bimanual irrigation/aspiration, with irrigation active generated spatter on the surgeons' gloves and gown extending to >16 cm below the neckline in surgeon 1 and > 5.5 cm below the neckline of surgeon 2. A small tear in the phacoemulsification irrigation sleeve, presented a worse-case scenario the greatest spatter. No contamination above the surgeons' neckline nor contamination of assistant occurred. CONCLUSIONS AND RELEVANCE: Cataract phacoemulsification generates microdroplets and spatter. Until further studies on SARS-CoV-2 transmission via microdroplets or aerosolisation of ocular fluid are reported, this pilot study only supports standard personal protective equipment.
Assuntos
COVID-19/epidemiologia , Catarata/epidemiologia , Transmissão de Doença Infecciosa/estatística & dados numéricos , Contaminação de Equipamentos/estatística & dados numéricos , Facoemulsificação/efeitos adversos , SARS-CoV-2 , Comorbidade , Feminino , Humanos , Período Intraoperatório , Masculino , Projetos PilotoRESUMO
BACKGROUND: Clinical ophthalmological guidelines encourage the assessment of potential benefits and harms when deciding whether to perform elective ophthalmology procedures during the COVID-19 pandemic, in order to minimize the risk of disease transmission. METHOD: We performed probability calculations to estimate COVID-19 infection status and likelihood of disease transmission among neovascular age-related macular degeneration patients and health-care workers during anti-VEGF procedures, at various community prevalence levels of COVID-19. We then applied the expected burden of COVID-19 illness and death expressed through health-adjusted life-years (HALYs) lost. We compared these results to the expected disease burden of severe visual impairment if sight protecting anti-VEGF injections were not performed. RESULTS: Our calculations suggest a wide range of contexts where the benefits of treatment to prevent progression to severe visual impairment or blindness are greater than the expected harms to the patient and immediate health care team due to COVID-19. For example, with appropriate protective equipment the benefits of treatment outweigh harms when the chance of progression to severe visual impairment is >0.044% for all scenarios where COVID-19 prevalence was 1/1000, even when the attack rate in the clinical setting is very high (5-43%). CONCLUSION: Unless COVID-19 prevalence is very high, the reduced disease burden from avoiding visual impairment outweighs the expected HALYs lost from COVID-19 transmission. This finding is driven by the fact that HALYs lost when someone suffers severe visual impairment for 5 years are equivalent to nearly 400 moderate cases of infectious disease lasting 2 weeks each.